Price $166.35 |
Market Cap
34.6B
|
Sector Health Care |
Div. Growth
7.70%
|
|
P/E
6.9
|
P/B
3.14
|
P/S
0.18
|
Dividend %
0.70%
|
|
P/CF
-
|
P/FCF
9.4
|
Op. Cash Flow
4.74M
|
FCF
17.5
|
|
Op. Margin
3.60%
|
Net Margin
2.60%
|
ROE
54.10%
|
ROI
27.90%
|
|
ROA
8.60%
|
EPS Growth
140.40%
|
Current Ratio
1.0
|
Debt/Equity
65.80%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Aralez Pharmaceuticals Inc (ARLZ) | $1.27 | - | - | 91.5M | Strong Buy |
| BioLife Solutions Inc (BLFS) | $3.40 | - | - | 30.8M | Strong Buy |
| Biostar Pharmaceuticals Inc (BSPM) | $1.45 | - | - | 4M | Strong Buy |
| Birner Dental Mgmt Services In (BDMS) | $12.25 | - | 6.50% | 25.1M | Strong Buy |
| Momenta Pharmaceuticals, Inc. (MNTA) | $16.75 | - | - | 1.27B | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
